Photo from wikipedia
Highlights • Symptomatic radionecrosis risk after brain metastases SRS is predicted by the V12Gy.• A history of whole-brain radiotherapy did not increase the risk.• Location, DS-GPA, previous surgery or vascular… Click to show full abstract
Highlights • Symptomatic radionecrosis risk after brain metastases SRS is predicted by the V12Gy.• A history of whole-brain radiotherapy did not increase the risk.• Location, DS-GPA, previous surgery or vascular disease were not predictors.
Keywords:
risk;
symptomatic radionecrosis;
individual risk;
risk symptomatic;
brain
Journal Title: Clinical and Translational Radiation Oncology
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Clinical and Translational Radiation Oncology
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!